What a week! The leading news story was without a doubt the Sarepta $SRPT FDA Advisory Committee meeting for their Duchenne Muscular Dystrophy drug, eteplirsen. Catch up on the news, analysis, sentiment and reactions for this and other top stories with the Biotech Tweets of the Week, curated by @23aloha and @BioDueDIligence. This week's edition features:
Biotech Tweets of the Week (April 25-29, 2016)
- A long Monday in Maryland $SRPT
- Let's Make a Deal! $MDVN $ABBV $GILD
- Sigh, more Valeant $VRX
- As seen on the stream (the best of the rest, including $ACAD $AMGN $BLCM $BMY $CNCE $CPRX $ONTY $PETX $RXDX $SGYP)
Biotech Tweets of the Week (April 25-29, 2016)
RSS Feed
